Positive atrial inotropic effect of dofetilide after cardioversion of atrial fibrillation or flutter

American Journal of Cardiology

Volumn 86, Issue 6, 2000, Pages 685-688

  Decara, Jeanne M ^a   Pollak, Arthur ^a   Dubrey, Simon ^a   Falk, Rodney H ^a  

^a BOSTON MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIARRHYTHMIC AGENT; DOFETILIDE; PLACEBO;

ARTICLE; CARDIOVERSION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; HEART ARRHYTHMIA; HEART ATRIUM ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART ATRIUM FLUTTER; HUMAN; INOTROPISM; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PRIORITY JOURNAL; TREATMENT OUTCOME;

AGED; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; ATRIAL FLUTTER; BLOOD FLOW VELOCITY; DOUBLE-BLIND METHOD; ECHOCARDIOGRAPHY, DOPPLER, COLOR; ELECTRIC COUNTERSHOCK; HEART RATE; HUMANS; MYOCARDIAL CONTRACTION; PHENETHYLAMINES; POTASSIUM CHANNEL BLOCKERS; RECURRENCE; STROKE VOLUME; SULFONAMIDES;

EID: 0034665974     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(00)01044-4     Document Type: Article

References (19)

1. Gwilt M., Arrowsmith J.E., Blackburn K.J., Burges R.A., Cross P.E., Dalrymple H.W., Higgins A.J. UK-68,798 a novel, potent and highly selective class III antiarrhythmic agent which blocks potassium channels in cardiac cells . J Pharmacol Exp Ther. 256:1991;318-324.
2. Tande P.M., Bjornstad H., Yang T., Refsum H. Rate-dependent class III antiarryhthmic action, negative chronotropy, and positive inotropy of a novel Ik blocking drug, UK-68,798 potent in guinea pig but no effect in rat myocardium. J Cardiovasc Pharmacol. 16:1990;401-409.
3. Baskin E.P., Serik C.M., Wallace A.A., Brookes L.M., Selnick H.G., Claremon D.A., Lynch J.J. Jr. Effects of new and potent methanesulfonanilide class III antiarrhythmic agents on myocardial refractoriness and contractility in isolated cardiac muscle. J Cardiovasc Pharmacol. 18:1991;406-414.
4. Wallace A.A., Stupienski R.F., Brookes L.M., Selnick H.G., Claremon D.A., Lynch J.J. Jr. Cardiac electrophysiologic and inotropic actions of new and potent methanesulfonanilide class III antiarrhythmic agents in anesthetized dogs. J Cardiovasc Pharmacol. 18:1991;687-695.
5. Hoffmeister H.M., Beyer M.E., Seipel L. Hemodynamic effects of antiarrhythmic compounds intrinsic effects and autonomic modulation . Am J Cardiol. 80:1997;24G-30G.
6. Pollak A., Falk R.H. Aggravation of postcardioversion atrial dysfunction by sotalol. J Am Coll Cardiol. 25:1995;665-671.
7. Schiller N.B., Shah P.M., Crawford M., DeMaria A., Devereux R., Feigenbaum H., Gutsgell H., Reichek N., Sahn D., Schnittger I. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. J Am Soc Echocardiogr. 2:1989;358-367.
8. Benjamin E.J., Levy D., Anderson K.M., Wolf P.A., Plehn J.F., Evans J.C., Comai K., Fuller D.L., Sutton M.S. Determinants of Doppler indexes of left ventricular diastolic function in normal subjects (The Framingham Heart Study). Am J Cardiol. 70:1992;508-514.
9. Mulvagh S., Quinones M.A., Kleiman N.S., Cheirif J.B., Zoghbi W.A. Estimation of left ventricular end-diastolic pressure from Doppler transmitral flow velocity in cardiac patients independent of systolic performance. J Am Coll Cardiol. 20:1992;112-119.
10. Dubrey S.W., Falk R.H. Optimal number of beats for the Doppler measurement of cardiac output in atrial fibrillation. J Am Soc Echocardiogr. 10:1997;67-71.
11. Grimm R.A., Stewart W.J., Arheart K.L., Thomas J.D., Klein A.L. Left atrial appendage "stunning" after electrical cardioversion of atrial flutter an attenuated response compared with atrial fibrillation as the mechanism for lower susceptibility to thromboembolic events . J Am Coll Cardiol. 29:1997;582-589.
12. Kitzman D.W., Sheikh K.H., Beere P.A., Philips J.L., Higginbotham M.B. Age related alterations of Doppler left ventricular filling indexes in normal subjects are independent of left ventricular mass, heart rate, contractility, and loading conditions. J Am Coll Cardiol. 18:1991;1243-1250.
13. Harrison M.R., Clifton G.D., Pennell A.T., DeMaria A.N., Cater A. Effect of heart rate on left ventricular diastolic transmitral flow velocity patterns assessed by Doppler echocardiography in normal subjects. Am J Cardiol. 67:1991;622-627.
14. Manning W.J., Silverman D.I., Katz S.E., Riley M.F., Come P.C., Doherty R.M., Munson J.T., Douglas P.S. Impaired left atrial mechanical function after cardioversion relation to the duration of atrial fibrillation . J Am Coll Cardiol. 23:1994;1535-1540.
15. Harjai K.J., Mobarek S.K., Cheirif J., Boulos L.M., Murgo J.P., Abi-Samra F. Clinical variables affecting recovery of left atrial mechanical function after cardioversion from atrial fibrillation. J Am Coll Cardiol. 30:1997;481-486.
16. Torp-Pedersen C., Moller M., Bloch-Thompsen P., Kober L., Sandoe E., Egstrup K., Agner A., Carlsen J., Videbaek J., Marchant B., Camm A.J. Dofetilide in patients with congestive heart failure and left ventricular dysfunction. N Engl J Med. 341:1999;857-865.
17. Hoffmeister H.M., Miller S., Seipel L. Effects of the new class III antiarrhythmic drug D-sotalol on contractile function of postischemic myocardium. J Cardiovasc Pharmacol. 17:1991;581-586.
18. Manning W.J., Silverman D.I., Katz S.E., Riley M.F., Doherty R.M., Munson J.T., Douglas P.S. Temporal dependence of the return of atrial mechanical function on the mode of cardioversion of atrial fibrillation to sinus rhythm. Am J Cardiol. 75:1995;624-626.
19. Falk R.H., DeCara J.M., Abascal V. Is pharmacologic cardioversion of atrial fibrillation really preferable to electrical cardioversion? J Am Coll Cardiol. 31:1998;1440.